Suppr超能文献

可用于免疫治疗的重新利用药物及寻找候选药物的策略

Repurposable Drugs for Immunotherapy and Strategies to Find Candidate Drugs.

作者信息

Sakai Norihiro, Kamimura Kenya, Terai Shuji

机构信息

Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, 1-757, Aasahimachi-Dori, Chuo-Ku, Niigata 951-8510, Japan.

Department of General Medicine, Niigata University School of Medicine, 1-757, Aasahimachi-Dori, Chuo-Ku, Niigata 951-8510, Japan.

出版信息

Pharmaceutics. 2023 Aug 24;15(9):2190. doi: 10.3390/pharmaceutics15092190.

Abstract

Conventional drug discovery involves significant steps, time, and expenses; therefore, novel methods for drug discovery remain unmet, particularly for patients with intractable diseases. For this purpose, the drug repurposing method has been recently used to search for new therapeutic agents. Repurposed drugs are mostly previously approved drugs, which were carefully tested for their efficacy for other diseases and had their safety for the human body confirmed following careful pre-clinical trials, clinical trials, and post-marketing surveillance. Therefore, using these approved drugs for other diseases that cannot be treated using conventional therapeutic methods could save time and economic costs for testing their clinical applicability. In this review, we have summarized the methods for identifying repurposable drugs focusing on immunotherapy.

摘要

传统的药物发现涉及重大步骤、时间和费用;因此,药物发现的新方法仍未得到满足,特别是对于患有难治性疾病的患者。为此,药物重新利用方法最近已被用于寻找新的治疗药物。重新利用的药物大多是先前已批准的药物,这些药物已经针对其他疾病的疗效进行了仔细测试,并且在经过仔细的临床前试验、临床试验和上市后监测后,其对人体的安全性得到了确认。因此,将这些已批准的药物用于传统治疗方法无法治疗的其他疾病,可以节省测试其临床适用性的时间和经济成本。在这篇综述中,我们总结了以免疫治疗为重点的可重新利用药物的识别方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7be0/10536625/50397afc644d/pharmaceutics-15-02190-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验